Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial Injury

Oxidative Medicine and Cellular Longevity
Michal ŘíhaPřemysl Mladěnka

Abstract

Iron and copper release participates in the myocardial injury under ischemic conditions and hence protection might be achieved by iron chelators. Data on copper chelation are, however, sparse. The effect of the clinically used copper chelator D-penicillamine in the catecholamine model of acute myocardial injury was tested in cardiomyoblast cell line H9c2 and in Wistar Han rats. D-Penicillamine had a protective effect against catecholamine-induced injury both in vitro and in vivo. It protected H9c2 cells against the catecholamine-induced viability loss in a dose-dependent manner. In animals, both intravenous D-penicillamine doses of 11 (low) and 44 mg/kg (high) decreased the mortality caused by s.c. isoprenaline (100 mg/kg) from 36% to 14% and 22%, respectively. However, whereas the low D-penicillamine dose decreased the release of cardiac troponin T (specific marker of myocardial injury), the high dose resulted in an increase. Interestingly, the high dose led to a marked elevation in plasma vitamin C. This might be related to potentiation of oxidative stress, as suggested by additional in vitro experiments with D-penicillamine (iron reduction and the Fenton reaction). In conclusion, D-penicillamine has protective potential agai...Continue Reading

References

Mar 15, 1976·Experimental Cell Research·B W Kimes, B L Brandt
Jan 1, 1990·Free Radical Biology & Medicine·Y J ApplebaumM Chevion
Dec 1, 1987·The American Journal of Physiology·R BolliR Roberts
Feb 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M ChevionN Kitrossky
Nov 14, 1997·Journal of Inorganic Biochemistry·L C Tran-HoG T Hefter
Dec 18, 2001·Cardiovascular Research·Nikolaos G FrangogiannisMark L Entman
Jun 1, 1964·Biochemistry·G R LENZ, A E MARTELL
May 1, 1962·Archives of Biochemistry and Biophysics·E J KUCHINSKAS, Y ROSEN
Feb 6, 2007·Lancet·Aftab AlaMichael L Schilsky
Jun 14, 2008·Free Radical Biology & Medicine·Wai Ho TangStephen Sum Man Chung
Jul 5, 2008·Nature Protocols·Guillermo RepettoJorge L Zurita
Nov 5, 2008·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Premysl MladenkaRadomír Hrdina
Nov 11, 2008·Toxicology·Premysl MladenkaRadomír Hrdina
Oct 9, 2009·Human & Experimental Toxicology·Premysl MladenkaPetr Nachtigal
Apr 13, 2010·Biochimie·Premysl MladenkaLuciano Saso
Jan 18, 2012·Current Atherosclerosis Reports·Jessica B Rubin, William B Borden
Mar 24, 2012·Canadian Journal of Physiology and Pharmacology·Libuše ZatloukalováRadomír Hrdina
Sep 18, 2012·Food Chemistry·Kateřina MacákováLuciano Saso
Apr 23, 2013·American Journal of Clinical Dermatology·Rim Ishak, Ossama Abbas
Dec 26, 2013·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Grażyna GromadzkaCzłonkowska Anna
Sep 10, 2014·Archives of Toxicology·Lisa M GaetkeChing K Chow
Apr 11, 2015·Journal of the American College of Cardiology·Borja IbáñezFrans Van de Werf

❮ Previous
Next ❯

Citations

Jan 10, 2018·Medicinal Research Reviews·Přemysl MladěnkaUNKNOWN TOX-OER and CARDIOTOX Hradec Králové Researchers and Collaborators

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
Assay
electrophoresis

Software Mentioned

LabChart
SigmaStat
Elements AR
NIS
GraphPad Prism

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.